Entity Common Stock, Shares Outstanding of LIGAND PHARMACEUTICALS INC from 01 Aug 2011 to 24 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
LIGAND PHARMACEUTICALS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 24 Feb 2026.
  • LIGAND PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding for the quarter ending 24 Feb 2026 was 19,941,141, a 3.6% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 19,941,141 +685,788 +3.6% 24 Feb 2026 10-K 27 Feb 2026 2025 FY
Q3 2025 19,681,720 +786,347 +4.2% 04 Nov 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 19,596,560 +1,327,610 +7.3% 05 Aug 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 19,255,353 +1,550,066 +8.8% 25 Feb 2025 10-K 28 Feb 2025 2024 FY
Q3 2024 18,895,373 +1,459,415 +8.4% 05 Nov 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 18,268,950 +913,693 +5.3% 05 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 17,705,287 +432,740 +2.5% 26 Feb 2024 10-K 29 Feb 2024 2023 FY
Q3 2023 17,435,958 +542,379 +3.2% 06 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 17,355,257 +472,506 +2.8% 04 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 17,272,547 +411,208 +2.4% 04 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 16,893,579 +181,938 +1.1% 04 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 16,882,751 +206,219 +1.2% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 16,861,339 +209,259 +1.3% 05 May 2022 10-Q 09 May 2022 2022 Q1
Q3 2021 16,711,641 +620,322 +3.9% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 16,676,532 +598,389 +3.7% 30 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 16,652,080 +602,377 +3.8% 03 May 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 16,091,319 -1,472,070 -8.4% 03 Nov 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 16,078,143 -2,933,331 -15% 04 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 16,049,703 -4,395,704 -22% 05 May 2020 10-Q 08 May 2020 2020 Q1
Q3 2019 17,563,389 -3,690,337 -17% 06 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 19,011,474 -2,092,367 -9.9% 07 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 20,445,407 -855,993 -4% 25 Feb 2019 10-K 28 Feb 2019 2018 FY
Q3 2018 21,253,726 +148,250 +0.7% 06 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 21,103,841 +50,347 +0.24% 07 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 21,301,400 +305,351 +1.5% 20 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 21,105,476 +205,287 +0.98% 31 Oct 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 21,053,494 +199,126 +0.96% 31 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 20,996,049 +173,605 +0.83% 01 May 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 20,919,894 09 Feb 2017 10-K 28 Feb 2017 2016 FY
Q3 2016 20,900,189 +974,435 +4.9% 01 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 20,854,368 +999,538 +5% 01 Aug 2016 10-Q 14 Nov 2016 2016 Q2
Q1 2016 20,822,444 +1,155,696 +5.9% 01 May 2016 10-Q 14 Nov 2016 2016 Q1
Q3 2015 19,925,754 -97,394 -0.49% 07 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 19,854,830 -925,926 -4.5% 01 Aug 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 19,666,748 -1,058,643 -5.1% 01 May 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 19,645,775 -968,749 -4.7% 12 Dec 2014 10-K/A 12 Dec 2014 2013 FY
Q3 2014 20,023,148 -387,099 -1.9% 31 Oct 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 20,780,756 +339,893 +1.7% 05 Aug 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 20,725,391 +517,143 +2.6% 07 May 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 20,614,524 14 Feb 2014 10-K 01 Dec 2014 2013 FY
Q3 2013 20,410,247 +445,791 +2.2% 29 Oct 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 20,440,863 +504,123 +2.5% 01 Aug 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 20,208,248 +473,829 +2.4% 01 Mar 2013 10-K 14 Mar 2013 2012 FY
Q3 2012 19,964,456 +290,763 +1.5% 06 Nov 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 19,936,740 +263,640 +1.3% 08 Aug 2012 10-Q/A 14 Nov 2012 2012 Q2
Q1 2012 19,734,419 30 Apr 2012 10-Q/A 14 Nov 2012 2012 Q1
Q4 2011 19,683,235 01 Feb 2012 10-K/A 14 Nov 2012 2011 FY
Q3 2011 19,673,693 04 Nov 2011 10-Q/A 10 Feb 2012 2011 Q3
Q2 2011 19,673,100 01 Aug 2011 10-Q/A 10 Feb 2012 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.